<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Congenital Zika virus infection: Clinical features, evaluation, and management of the neonate
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Congenital Zika virus infection: Clinical features, evaluation, and management of the neonate
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Congenital Zika virus infection: Clinical features, evaluation, and management of the neonate
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Karin Nielsen-Saines, MD, MPH
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Morven S Edwards, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Karen M Puopolo, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carrie Armsby, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jun 22, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H3147145703">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Zika virus is an arthropod-borne flavivirus transmitted by mosquitoes. Congenital Zika virus infection is associated with severe congenital anomalies. This topic will discuss issues related to newborns congenitally infected with Zika virus. Zika virus infection in pregnant women and other issues related to Zika virus infection, including epidemiology, travel advisories, and infection in older children and adults, are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/107211.html" rel="external">
          "Zika virus infection: Evaluation and management of pregnant patients"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/106169.html" rel="external">
          "Zika virus infection: An overview"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H333500268">
         <span class="h1">
          PATHOGENESIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Zika virus is a neurotropic virus that particularly targets neural progenitor cells [
         <a href="#rid1">
          1
         </a>
         ]. Murine and human placental studies support the hypothesis that maternal infection leads to placental infection and injury, followed by transmission of the virus to the fetal brain, where it kills neuronal progenitor cells and disrupts neuronal proliferation, migration, and differentiation, which slows brain growth and reduces viability of neural cells [
         <a href="#rid1">
          1-7
         </a>
         ]. Zika virus is also associated with a higher rate of fetal loss throughout pregnancy, including stillbirths. Placental insufficiency is the mechanism postulated to induce fetal loss later in pregnancy; however, significant placental inflammation has not been described [
         <a href="#rid3">
          3,8-10
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/107211.html" rel="external">
          "Zika virus infection: Evaluation and management of pregnant patients", section on 'Hydrops, fetal loss/death, and preterm birth'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H853996931">
         <span class="h1">
          HISTOPATHOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         A series from Brazil described histopathologic findings in tissue from two newborns with microcephaly and severe arthrogryposis who died shortly after birth and tissue from a microcephalic infant who died at age two months [
         <a href="#rid11">
          11
         </a>
         ]. In all cases, the mothers lived in Brazil and had symptoms consistent with Zika virus infection in the first trimester. The infants were born at 36, 38, and 38 weeks of gestation. Multiple congenital malformations were noted, including a wide range of brain abnormalities, craniofacial malformations, craniosynostosis, pulmonary hypoplasia, and multiple congenital contractures, consistent with fetal akinesia deformation sequence or severe arthrogryposis. In these three cases, there was immunohistochemical and molecular evidence of virus persistence in the brain. The range of neuropathology included ventriculomegaly, lissencephaly (which commonly aligns with microcephaly), cerebellar hypoplasia, and ventriculomegaly, all of which have been observed in other cases studied [
         <a href="#rid12">
          12
         </a>
         ].
        </p>
        <p>
         In the histopathologic reports, brains of infant with congenital Zika infection also showed evidence of tissue destruction, including calcifications, gliosis, and necrosis [
         <a href="#rid11">
          11
         </a>
         ]. The presence of necrosis suggests ongoing cellular injury, consistent with the demonstrated continued viral presence. Thus, the patterns of injury are likely to follow from cellular injury at the time of infection as well as subsequent damage as the brain develops. Evidence from cell culture systems places the neuronal precursor cell as a crucial target for Zika virus infection resulting in cell death [
         <a href="#rid13">
          13
         </a>
         ]. Loss of these cells early in development has been reported to substantially reduce the number of neurons generated and result in small brains without cortical gyration [
         <a href="#rid14">
          14
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1811905446">
         <span class="h1">
          GEOGRAPHIC DISTRIBUTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Updates regarding the geographic distribution of Zika virus may be viewed at the
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.cdc.gov%2Fzika%2Fgeo%2Findex.html&amp;token=mjmpv7xMHRIW2nr%2B3NCnsadTqEOxwzb4nAvk%2FgFzFslzWisih6gjiMid9z55bPRS&amp;TOPIC_ID=109681" target="_blank">
          United States Centers for Disease Control and Prevention website
         </a>
         and the
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.paho.org%2Fhq%2Findex.php%3Foption%3Dcom_topics%26view%3Darticle%26id%3D427%26Itemid%3D41484&amp;token=Wd9AQCyNDPj1FejeQDq7FypoGPLk91irS3vr2G4ZgFDsPEQXGNTTI8%2FvvYAFym2lX9m%2BIsBGn5XluSZ3w3gZUjt8aDeYpqYAiC5YQHaAfHUbRCGbgmCZ041KXyhOFnAe&amp;TOPIC_ID=109681" target="_blank">
          Pan American Health Organization/World Health Organization website
         </a>
         .
        </p>
        <p>
         The epidemiology of Zika virus infection is reviewed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/106169.html" rel="external">
          "Zika virus infection: An overview", section on 'Epidemiology'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1959677416">
         <span class="h1">
          RISK OF VERTICAL TRANSMISSION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risk for vertical transmission exists throughout pregnancy in mothers with both symptomatic and asymptomatic Zika virus infection; however, the greatest risk of serious fetal sequelae appears to be with first- and second-trimester infection. The risk of vertical transmission is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/107211.html" rel="external">
          "Zika virus infection: Evaluation and management of pregnant patients", section on 'Frequency of vertical transmission'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2903400231">
         <span class="h1">
          CLINICAL FEATURES OF CONGENITAL ZIKA SYNDROME
         </span>
        </p>
        <p class="headingAnchor" id="H2678913088">
         <span class="h2">
          In utero
         </span>
         <span class="headingEndMark">
          —
         </span>
         In utero Zika virus infection can result in fetal growth restriction and serious sequelae related to the central nervous system (CNS) [
         <a href="#rid10">
          10,12,15-22
         </a>
         ]. In a review of the major findings of 14 studies with adequate radiologic assessment of suspected or confirmed Zika virus-infected fetuses, the most common abnormalities among the 66 fetuses included [
         <a href="#rid5">
          5
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ventriculomegaly (33 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Microcephaly (24 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intracranial calcifications (27 percent)
        </p>
        <p>
        </p>
        <p>
         Fetal loss occurs in approximately 5 to 10 percent of pregnancies with documented Zika virus infection [
         <a href="#rid10">
          10,23
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/107211.html" rel="external">
          "Zika virus infection: Evaluation and management of pregnant patients", section on 'Fetal ultrasonography'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3497897347">
         <span class="h2">
          Findings in the newborn
         </span>
        </p>
        <p class="headingAnchor" id="H2971919706">
         <span class="h3">
          Frequency of congenital abnormalities
         </span>
         <span class="headingEndMark">
          —
         </span>
         Estimates of the overall rates of any abnormality among fetuses and infants exposed to Zika virus during gestation range from 5 to 40 percent [
         <a href="#rid10">
          10,23-29
         </a>
         ]. The wide range likely reflects differences in study design, populations studied, maternal Zika case definition (possible versus confirmed), and the range of clinical abnormalities included. Estimates of the risk of microcephaly with in utero Zika virus exposure range from 1 to 6 percent [
         <a href="#rid10">
          10,23,24,26-30
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/107211.html" rel="external">
          "Zika virus infection: Evaluation and management of pregnant patients", section on 'Potential consequences of vertical transmission'
         </a>
         .)
        </p>
        <p>
         In a report of the United States Zika Pregnancy and Infant Registry, among the 6799 live-born infants reported to the registry from late 2015 through early 2018, 4.6 percent had one or more Zika-associated congenital abnormalities [
         <a href="#rid29">
          29
         </a>
         ]. In the subset of infants with confirmed maternal Zika virus infection (ie, positive Zika virus nucleic acid amplification test during pregnancy), 6.1 percent had Zika-associated congenital abnormalities. The most common abnormalities were microcephaly (3 percent); corpus callosum abnormalities (0.9 percent); intracranial calcification (0.9 percent); abnormal cortical gyral patterns (0.8 percent); ventriculomegaly (0.8 percent); cerebral or cortical atrophy (0.6 percent); chorioretinal atrophy, scarring, or pigmentary changes (0.7 percent); and optic nerve abnormalities (0.5 percent). Approximately one-third of affected infants had more than one abnormality.
        </p>
        <p>
         In a meta-analysis of 13 cohort studies from Brazil that included data on 1341 liveborn infants with in utero Zika virus exposure, 15 percent of newborns were small for gestational age (SGA) and 3.5 percent had microcephaly at birth [
         <a href="#rid28">
          28
         </a>
         ]. Among the 565 infants who underwent neuroimaging, 5 percent had at least one abnormal finding, most commonly calcifications and/or ventriculomegaly. Among a subset of approximately 30 percent of the birth cohort who were evaluated at a median age of 11.7 months, the following findings were noted:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Seizures (6 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abnormal tone (7 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abnormal ophthalmologic examination (7 percent)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Failed audiologic test (3 percent)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H866030733">
         <span class="h3">
          Clinical findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         The principal clinical features of congenital Zika syndrome (CZS) include microcephaly, facial disproportion, hypertonia/spasticity, hyperreflexia, seizures, irritability, arthrogryposis, ocular abnormalities, and sensorineural hearing loss (SNHL)  (
         <a class="graphic graphic_picture graphicRef109690" href="/z/d/graphic/109690.html" rel="external">
          picture 1
         </a>
         and
         <a class="graphic graphic_table graphicRef110678" href="/z/d/graphic/110678.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid1">
          1,22,31,32
         </a>
         ]. In a comprehensive review of published reports (including 11 single case reports, 21 case series, and 1 cohort study), the following were identified as unique features of CZS that are rarely seen with other congenital infections [
         <a href="#rid33">
          33
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe microcephaly with partially collapsed skull
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Thin cerebral cortices with subcortical calcifications
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Macular scarring and focal pigmentary retinal mottling
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Congenital contractures (arthrogryposis)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Marked early hypertonia
        </p>
        <p>
        </p>
        <p>
         However, the full spectrum of the syndrome is broad; more subtle manifestations of Zika virus infection may become apparent as infants age [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Microcephaly
         </strong>
         – Microcephaly is an important clinical finding in infants with CZS [
         <a href="#rid16">
          16,18,19,34-38
         </a>
         ]; however, normal head circumference does not exclude CZS [
         <a href="#rid39">
          39,40
         </a>
         ]. (See
         <a class="local">
          'Assessment for microcephaly'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Prospective studies have demonstrated that the overall frequency of microcephaly following in utero Zika virus exposure is approximately 1 to 6 percent [
         <a href="#rid10">
          10,23,24,26-28,30,41
         </a>
         ]. Microcephaly following in utero exposure to Zika virus infection can be primary (noted at birth) or secondary (developing in the first months of life) [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Both proportionate and disproportionate microcephaly have been reported in infants with CZS. "Proportionate microcephaly" refers to SGA infants who have a small head circumference that is proportionate to their overall small size; "disproportionate microcephaly" refers to infants who have small head circumference with normal weight and length. Neurologic outcomes do not appear to differ between infants with proportional and disproportional microcephaly [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Microcephaly appears to be a consequence of Zika infection early in pregnancy; however, proportionate microcephaly has been observed in the offspring of women infected as late as the third trimester of pregnancy [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Although rare, resolution of microcephaly has been reported in two children with antenatal Zika virus infection [
         <a href="#rid41">
          41
         </a>
         ]. One had surgically treated craniosynostosis and the other had proportional microcephaly that improved over time as the child grew.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Craniofacial disproportion
         </strong>
         – Craniofacial disproportion is seen in most affected infants and is related to the degree of microcephaly (ie, the face appears large in relation to the small head).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cutis gyrata
         </strong>
         – In infants with severe microcephaly, "cutis gyrata," or redundant scalp (skin folds on the scalp due to continued growth of the skin despite poor brain growth), may be observed [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Craniosynostosis
         </strong>
         – Craniosynostosis may be seen in severely affected infants with CZS [
         <a href="#rid22">
          22,43
         </a>
         ]. In one case series of 23 severely affected infants, 78 percent had a closed anterior fontanel at birth [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          SGA
         </strong>
         – Among infants with in utero Zika virus exposure, approximately 15 percent are SGA at birth [
         <a href="#rid28">
          28
         </a>
         ]. The prevalence of SGA among infants with other clinical findings of CZS is approximately 30 to 40 percent [
         <a href="#rid22">
          22,32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Seizures
         </strong>
         – Seizures may occur due to underlying brain malformations, but may also be present in children without apparent CNS abnormalities [
         <a href="#rid10">
          10,44,45
         </a>
         ]. In a systematic review and meta-analysis of 14 observational studies including a total of 903 infants and children diagnosed with CZS, reported rates of seizure disorders among patients with CZS ranged from 35 to 79 percent [
         <a href="#rid45">
          45
         </a>
         ]. Infantile spasms were the primary seizure type; focal seizures were more prevalent in patients who developed epilepsy after one year of age. Seizures in patients with CZS tend to be refractory. In one study of 65 children with CZS-related epilepsy, only 46 percent responded to antiepileptic treatment [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Abnormal neuromotor tone
         </strong>
         – Infants with CZS commonly exhibit hypertonia, spasticity, hyperreflexia, dysphagia, and feeding difficulties [
         <a href="#rid10">
          10,31,47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Contractures and orthopedic abnormalities
         </strong>
         – Arthrogryposis and club foot have been reported and are likely neurogenic in origin (ie, due to fixed posture in utero) [
         <a href="#rid11">
          11,48
         </a>
         ]. Hip dysplasia is a later manifestation related to severe contractures. In one series of 64 children with severe motor impairment due to CZS, 41 percent were diagnosed with hip dysplasia at a median age of 23 months [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Ocular abnormalities
         </strong>
         – The overall frequency of ocular abnormalities among Zika virus-exposed infants (symptomatic and asymptomatic) is approximately 6 to 7 percent [
         <a href="#rid41">
          41,50,51
         </a>
         ]. Among infants with CZS, approximately one-quarter have ocular abnormalities [
         <a href="#rid52">
          52,53
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The most commonly reported eye findings include macular abnormalities (eg, focal pigmentary retinal mottling and chorioretinal atrophy) and optic nerve abnormalities (eg, optic nerve hypoplasia, increased cup-to-disk ratio, and pallor) [
         <a href="#rid33">
          33,52-56
         </a>
         ]. Other reported findings include pigmentary clumping and chorioretinal atrophy outside of the macula; subretinal hemorrhages; coloboma; vascular tortuosity, straightening, and attenuation; abnormal termination of the retinal vessels; and focal areas of vascular dilation [
         <a href="#rid52">
          52,53,57-60
         </a>
         ]. Structural abnormalities (eg, microcornea, microphthalmia, iris colobomas, intraocular calcification, lens subluxation, cataracts), congenital glaucoma, strabismus, and nystagmus have also been reported [
         <a href="#rid17">
          17,52-56,59,61-65
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Ophthalmologic lesions in CZS do not appear to progress over time [
         <a href="#rid53">
          53
         </a>
         ]. Cortical visual impairment may be the main cause of blindness in infants with CZS [
         <a href="#rid59">
          59,66,67
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Vision impairment is common in infants and children with CZS. In a study of 173 infants with congenital Zika virus infection who underwent eye examination, 30 percent had impaired visual function (ie, defined as inability to fix and follow) [
         <a href="#rid68">
          68
         </a>
         ]. The risk was highest in infants with associated eye abnormalities (of whom 84 percent were unable to fix and follow) and those with microcephaly or other neurologic abnormality (of whom 60 percent were unable to fix and follow). In light of these findings, simple assessment of visual acuity by testing the infant's ability to fix and follow has been proposed as a screening tool for identification of potential symptomatic cases of congenital Zika virus infection in resource-limited settings where pediatric ophthalmologists are not available [
         <a href="#rid68">
          68
         </a>
         ]. (See
         <a class="local">
          'Additional evaluation'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hearing loss
         </strong>
         – Hearing loss has been reported in approximately 5 to 10 percent of infants with in utero Zika virus exposure [
         <a href="#rid28">
          28,41,50,69
         </a>
         ]. Hearing loss is particularly common among infants with microcephaly [
         <a href="#rid69">
          69
         </a>
         ]. Delayed-onset hearing loss has not yet been reported.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Cardiac anomalies
         </strong>
         – In two studies including a total of 223 infants with presumed or confirmed CZS, the reported prevalence of congenital heart disease (CHD) was approximately 10 to 15 percent [
         <a href="#rid70">
          70,71
         </a>
         ]. This rate is considerably higher than the prevalence of CHD in the general population (which is approximately 1 percent). Most of the CHD defects in these studies were nonsevere, including secundum atrial septal defects, patent ductus arteriosus, and small muscular or perimembranous ventricular septal defects (VSDs). Only one of the 223 infants had a hemodynamically significant CHD defect (a large membranous VSD). (See
         <a class="medical medical_review" href="/z/d/html/5754.html" rel="external">
          "Isolated atrial septal defects (ASDs) in children: Classification, clinical features, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5787.html" rel="external">
          "Isolated ventricular septal defects (VSDs) in infants and children: Anatomy, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1421137060">
         <span class="h3">
          Neuroimaging findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         Neuroradiologic abnormalities are detected in the majority of infants with CZS who undergo neuroimaging. The risk of having neurologic abnormalities on imaging studies is highest in infants born to mothers infected in the first trimester [
         <a href="#rid43">
          43
         </a>
         ].
        </p>
        <p>
         Findings may include  (
         <a class="graphic graphic_diagnosticimage graphicRef109691 graphicRef109692 graphicRef126225" href="/z/d/graphic/109691.html" rel="external">
          image 1A-C
         </a>
         ) [
         <a href="#rid12">
          12,21,43,72-74
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Intracranial calcifications
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ventriculomegaly
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cortical atrophy
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Reduced brain volume
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Delayed myelination
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Simplified gyral patterns (eg, polymicrogyria, pachygyria, lissencephaly)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Thinning or hypoplasia of the corpus callosum
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hypoplasia of the brainstem and cerebellum
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Enlargement of the cisterna magna
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Increased extra-axial fluid spaces
        </p>
        <p>
        </p>
        <p>
         Intracranial calcifications most commonly occur at the junction between the cortical and subcortical white matter and may also occur in other locations such as the basal ganglia, thalamus, periventricular region, brainstem, and cerebellum [
         <a href="#rid12">
          12,43,73
         </a>
         ]. The finding of calcification along the gray matter-white matter junction can help distinguish congenital Zika virus infection from other congenital infections (eg, cytomegalovirus) in which calcifications are typically punctate. (See
         <a class="medical medical_review" href="/z/d/html/14430.html" rel="external">
          "Congenital cytomegalovirus infection: Clinical features and diagnosis", section on 'Neuroimaging'
         </a>
         .)
        </p>
        <p>
         In a case series of 37 affected infants who underwent follow-up imaging at approximately one year of age, calcifications had diminished in number, size, or density in most children [
         <a href="#rid75">
          75
         </a>
         ]. However, the reduction in calcifications did not correlate with clinical improvement as most patients in this series had severe neurologic impairment; 40 percent went on to develop hydrocephalus and required ventriculoperitoneal shunt placement.
        </p>
        <p class="headingAnchor" id="H150029068">
         <span class="h1">
          EVALUATION
         </span>
        </p>
        <p class="headingAnchor" id="H429011428">
         <span class="h2">
          Overview
         </span>
         <span class="headingEndMark">
          —
         </span>
         Initial evaluation of infants born to mothers with laboratory evidence of Zika virus infection and/or infants with findings suggestive of congenital Zika infection in the setting of a maternal epidemiologic link should include  (
         <a class="graphic graphic_algorithm graphicRef109689" href="/z/d/graphic/109689.html" rel="external">
          algorithm 1
         </a>
         ) [
         <a href="#rid76">
          76
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A thorough physical examination (with measurement of head [occipitofrontal] circumference, length, and weight; assessment of gestational age [GA]; and examination for neurologic abnormalities and dysmorphic features).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Laboratory testing to detect Zika virus. (See
         <a class="local">
          'Laboratory evaluation'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Head ultrasonography. (See
         <a class="local">
          'Neuroimaging'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Standard newborn hearing assessment. (See
         <a class="medical medical_review" href="/z/d/html/4985.html" rel="external">
          "Screening the newborn for hearing loss"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Additional evaluation (including comprehensive eye examination, laboratory tests, and specialist consultation) is performed in neonates with positive maternal Zika virus testing
         <strong>
          and
         </strong>
         clinical evidence of congenital Zika syndrome (CZS). (See
         <a class="local">
          'Additional evaluation'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3458119454">
         <span class="h2">
          Assessment for microcephaly
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is no standard definition for diagnosis of microcephaly. (See
         <a class="medical medical_review" href="/z/d/html/2839.html" rel="external">
          "Microcephaly in infants and children: Etiology and evaluation"
         </a>
         .)
        </p>
        <p>
         The World Health Organization (WHO) and the United States Centers for Disease Control and Prevention (CDC) define microcephaly as occipitofrontal circumference (head circumference) more than two standard deviations below the mean (ie, less than the 3
         <sup>
          rd
         </sup>
         percentile) based on standard growth charts for sex, age, and GA at birth (eg,
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fintergrowth21.tghn.org%2Fglobal-perinatal-package%2F&amp;token=O2XRSg3dvuTe%2Fs9F89y28raw2oGFudWq6woWSVnmaHT8Fehf9krRH3OFTs6xIVghbYuKN76jpoRPEfwFl7zSbQ%3D%3D&amp;TOPIC_ID=109681" target="_blank">
          INTERGROWTH-21st standards
         </a>
         (
         <a class="graphic graphic_table graphicRef107271" href="/z/d/graphic/107271.html" rel="external">
          table 2
         </a>
         )) [
         <a href="#rid77">
          77-79
         </a>
         ]. Severe microcephaly is defined as head circumference more than three standard deviations below the mean [
         <a href="#rid79">
          79
         </a>
         ].
        </p>
        <p>
         Although this definition of microcephaly identifies 3 percent of infants as possibly abnormal, it is a practical screening tool since percentile growth charts are typically used for assessing growth in pediatric health care, and this is the lowest cutoff on these charts. Both the CDC and WHO recommend careful clinical evaluation of these infants before making a definitive diagnosis of microcephaly and determining appropriate follow-up [
         <a href="#rid80">
          80
         </a>
         ]. If an infant's occipitofrontal circumference is ≥3
         <sup>
          rd
         </sup>
         percentile but is notably disproportionate to the length of the infant, or if the infant has deficits related to the central nervous system, additional evaluation for Zika virus infection may also be appropriate.
        </p>
        <p>
         It is important to obtain multiple measurements of the occipitofrontal circumference serially over time since inaccurate measurements are common. This was demonstrated in a report from the United States Zika Pregnancy and Infant Registry of 84 infants who initially were reported to have microcephaly (ie, occipitofrontal circumference &lt;3
         <sup>
          rd
         </sup>
         percentile) at birth and who had subsequent serial measurements reported [
         <a href="#rid81">
          81
         </a>
         ]. Only one-third of the infants continued to have microcephaly on subsequent measurements, whereas 45 percent were felt to have inaccurate initial measurements and 23 percent were assessed as having accurate initial measurements that subsequently improved to ≥3
         <sup>
          rd
         </sup>
         percentile.
        </p>
        <p class="headingAnchor" id="H3909546514">
         <span class="h2">
          Laboratory evaluation
         </span>
        </p>
        <p class="headingAnchor" id="H637157656">
         <span class="h3">
          Whom to test
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infants who warrant Zika virus laboratory testing include either of the following  (
         <a class="graphic graphic_algorithm graphicRef109689" href="/z/d/graphic/109689.html" rel="external">
          algorithm 1
         </a>
         ) [
         <a href="#rid76">
          76
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Newborns of mothers with laboratory evidence for Zika virus infection during pregnancy. (See
         <a class="medical medical_review" href="/z/d/html/107211.html" rel="external">
          "Zika virus infection: Evaluation and management of pregnant patients", section on 'Maternal diagnosis and diagnostic classification'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Newborns who have clinical or neuroimaging findings suggestive of CZS and a maternal epidemiologic link suggesting possible transmission (which includes paternal exposure), regardless of maternal Zika virus test results. A normal head circumference does not exclude the possibility of Zika virus congenital syndrome [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H135620978">
         <span class="h3">
          Tests to obtain
         </span>
         <span class="headingEndMark">
          —
         </span>
         Laboratory testing for Zika virus infection in the neonate includes the following [
         <a href="#rid76">
          76,82
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serum and urine for Zika virus RNA via real-time reverse transcription polymerase chain reaction (rRT-PCR).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Serum Zika virus immunoglobulin M (IgM) enzyme-linked immunosorbent assay (ELISA).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If cerebrospinal fluid (CSF) is available, test CSF for Zika virus RNA (via rRT-PCR) as well as Zika virus IgM. CSF specimens need not be collected for the sole purpose of Zika virus testing [
         <a href="#rid76">
          76,82
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Instructions for collecting and shipping infant serum are available through the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.cdc.gov%2Fzika%2Fhc-providers%2Ftest-specimens-at-time-of-birth.html&amp;token=KQJs%2FXtNS6TcoD04MMxj0gLagHRsNZM68WmwtCv6%2BZN7DCwpIf%2FB2BxWBhr%2F7dLMAEhP5z9LclprncoEHC7xxvYSp%2BHOZOVaDOkoeBA2maU%3D&amp;TOPIC_ID=109681" target="_blank">
          CDC website
         </a>
         . The initial samples should be collected from the infant within the first few days after birth if possible to distinguish between congenital, perinatal, and postnatal infection. Testing cord blood is discouraged because it can yield false positive results [
         <a href="#rid76">
          76
         </a>
         ]. Testing should be performed early in the newborn period because the window for viral detection is relatively short [
         <a href="#rid83">
          83
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H443969588">
         <span class="h3">
          Interpretation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Interpretation of Zika virus testing in the newborn is as follows  (
         <a class="graphic graphic_table graphicRef115662" href="/z/d/graphic/115662.html" rel="external">
          table 3
         </a>
         ) [
         <a href="#rid76">
          76
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Confirmed infection
         </strong>
         – Detection of Zika virus RNA by rRT-PCR in infant serum, urine, or CSF collected within the first few days of life confirms the diagnosis of congenital Zika virus infection [
         <a href="#rid76">
          76
         </a>
         ]. IgM antibodies may be positive or negative.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Probable infection
         </strong>
         – A negative rRT-PCR with positive Zika virus IgM indicates probable congenital Zika virus infection. However, false-positive results can occur from cross-reacting IgM antibodies or nonspecific reactivity [
         <a href="#rid84">
          84
         </a>
         ]. Results of maternal testing are particularly important in this setting. A positive IgM in the infant in the context of confirmed maternal Zika virus infection during pregnancy is highly suggestive of congenital Zika virus infection. A positive IgM in the CSF is also highly suggestive of congenital Zika virus infection.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If the infant's initial IgM is positive but the mother did not have sufficient testing to definitively confirm or exclude Zika virus infection during pregnancy, then additional testing should be performed to exclude a false positive IgM result. (See
         <a class="local">
          'Excluding false positive IgM results'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Infection unlikely
         </strong>
         – If both rRT-PCR and IgM are negative, congenital infection is unlikely [
         <a href="#rid76">
          76
         </a>
         ]. A negative rRT-PCR result alone does not exclude congenital infection because viremia may be transient. The duration of viral shedding in newborns infected in utero is not known. A case report described a newborn who was viremic for at least 67 days after birth [
         <a href="#rid85">
          85
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Additional data are needed to determine if Zika infection can be definitively excluded on the basis of negative rRT-PCR and IgM, particularly in infants with a known Zika exposure. Some infants may not shed virus in their urine and therefore PCR testing is negative despite confirmed maternal infection by PCR during pregnancy. It is possible that there may be a delay in forming IgM antibodies (as can be seen in congenital rubella and cytomegalovirus infection). Further data are necessary to clarify this question.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3655772490">
         <span class="h3">
          Excluding false positive IgM results
         </span>
         <span class="headingEndMark">
          —
         </span>
         Interpretation of serologic findings, particularly ELISA-based techniques, is complex because serologic tests for Zika virus can cross react with dengue antibodies in endemic areas. For this reason, neutralization assays (eg, plaque reduction neutralization test [PRNT] or virus neutralization test [VNT]) may be required for confirmation.
        </p>
        <p>
         Neutralization tests are particularly useful if the infant has a negative rRT-PCR with positive IgM and the mother did not have sufficient testing performed during pregnancy to definitively confirm or exclude Zika virus infection. In this setting, a positive IgM in the infant may represent true congenital Zika virus infection (true positive), or it may be a false positive due to cross reactivity with dengue antibodies or nonspecific reactivity. The neutralization test confirms the specificity of the antibodies.
        </p>
        <p>
         Neutralization tests cannot distinguish between maternally transferred antibody versus infant antibody. Thus, a positive Zika virus PRNT or VNT result in the infant indicates that the infant was exposed to Zika virus antenatally. While this supports the diagnosis of congenital infection (particularly if the infant is symptomatic), it does not definitively confirm that the infant is infected.
        </p>
        <p>
         Studies conducted in children with confirmed congenital Zika infection have demonstrated that neutralizing antibodies do not persist after maternal antibodies wane [
         <a href="#rid86">
          86
         </a>
         ]. Thus, a negative Zika virus PRNT or VNT in a child &gt;12 months old does not exclude antenatal Zika virus infection.
        </p>
        <p>
         PRNT assays are not performed in routine clinical laboratory tests but may be available through state and local health departments. They are also available through the CDC. PRNT assays are complex and cumbersome and need to be performed in laboratories familiar with this technique. Additional resources for testing are available through the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fnam04.safelinks.protection.outlook.com%2F%3Furl%3Dhttp%253A%252F%252Fwww.cdc.gov%252Fzika%252Fhc-providers%252Ftypes-of-tests.html%26data%3D05%7C01%7CDaniel.Connolly%2540wolterskluwer.com%7C6953d9c708e94d6631d108db7342886a%7C8ac76c91e7f141ffa89c3553b2da2c17%7C0%7C0%7C638230501816693573%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%253D%7C3000%7C%7C%7C%26sdata%3DgcHywls3qTsvnZ%252FiDyouyBtosiR7N6HW0rm%252F39mXtuQ%253D%26reserved%3D0&amp;token=ObKkmrzHR%2Ff5%2FqlC3by1QP4GvNGS6pLZ78ztlKy7IOiNqvMuTXsjz8NoE3ZTsqzPy%2FG673L7GYChj2yxOmqIUNRNHY4Yw%2BhTLpmlVf5ETuyKUcjw0nteVwTKg5%2F72PBTCXZ6eBvjRkA%2FZ7KCGVTgn%2B9NcahKHN27nR67hN2p2BZN%2FVoJReCsRLk7P%2BXCFc9cq5f3lBcTKa0n%2F2xsVLS5i0rdkEJ34ZcbK1zQNuF2PkQ83D8DYA%2FfO6T3lTEI5BHr3GK1uZXxOnOETwWB4onQFtsVzWmSQrg9JStiHN7hXII%2B9xZcdhCVL5UibhGz8cYDUtXOZC4hOfSpf7DHKGB61lh%2FIwXeJyADcBLdHfh1ykCjDBYIdrGj20r70gAbaLXuTfe%2FJLQIQguGmMBpc2sTi65%2BezqXO4Ie62HshFvqTzK%2Fh3VrB4rb7%2B4O5zlW7lvFuMx0afIedQJ8tk%2FNz1LIlg%3D%3D&amp;TOPIC_ID=109681" target="_blank">
          CDC website
         </a>
         .
        </p>
        <p>
         In addition to testing the neonate, maternal serum should be tested for Zika virus IgM and neutralizing antibodies and dengue virus IgM and neutralizing antibodies if this testing was not already performed during pregnancy. Histopathologic examination of the placenta and umbilical cord can also be helpful. (See
         <a class="medical medical_review" href="/z/d/html/107211.html" rel="external">
          "Zika virus infection: Evaluation and management of pregnant patients", section on 'Approach to maternal laboratory testing and fetal imaging'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/107211.html" rel="external">
          "Zika virus infection: Evaluation and management of pregnant patients", section on 'Disposition of the placenta'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4118380079">
         <span class="h2">
          Neuroimaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         All neonates with suspected or possible congenital Zika infection should have head ultrasonography performed as an initial screening imaging study. If any abnormalities are detected, additional neuroimaging with computed tomography (CT) and/or magnetic resonance imaging (MRI) may be warranted to provide further detail. CT is most sensitive for detection of intracranial calcifications. MRI is more sensitive for characterization of structural brain disease. Consultation with a neurologist is advised to guide appropriate neuroimaging.
        </p>
        <p>
         If the screening head ultrasound is negative or is not interpretable, yet the clinical findings are suspicious for neurologic involvement (eg, seizures, microcephaly, abnormal or asymmetric tone), a more sensitive imaging study should be performed (ie, CT and/or MRI). Consultation with a neurologist is also advised in these circumstances.
        </p>
        <p>
         Neuroimaging findings typical of CZS are described above. (See
         <a class="local">
          'Neuroimaging findings'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H1955978054">
         <span class="h2">
          Additional evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         For infants with positive maternal laboratory testing for Zika virus
         <strong>
          and
         </strong>
         clinical evidence of congenital Zika infection (ie, microcephaly and/or other congenital anomalies consistent with CZS), a comprehensive evaluation should be performed. The initial clinical evaluation can be completed before hospital discharge or as an outpatient, taking into account hospital capabilities and needs of the family. Transfer to a facility with access to pediatric subspecialty care typically is not necessary unless there is an urgent clinical need (eg, refractory seizures, respiratory failure).
        </p>
        <p>
         The evaluation includes  (
         <a class="graphic graphic_algorithm graphicRef109689" href="/z/d/graphic/109689.html" rel="external">
          algorithm 1
         </a>
         ) [
         <a href="#rid76">
          76
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Comprehensive eye examination by an ophthalmologist and evaluation for possible cortical visual impairment prior to discharge from the hospital or within one month of birth
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Testing of auditory brainstem response to assess hearing (see
         <a class="medical medical_review" href="/z/d/html/4985.html" rel="external">
          "Screening the newborn for hearing loss", section on 'Automated auditory brainstem response'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Laboratory tests, including complete blood count and metabolic panel with liver function tests
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Consultation with the following specialists are usually indicated:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A neurologist for comprehensive neurologic examination and determination of appropriate advanced neuroimaging and electroencephalogram. Evaluation by a neurologist should generally occur within one month after birth.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         An infectious disease specialist to assist in the diagnostic evaluation for Zika virus and other congenital infections (eg, syphilis, toxoplasmosis, rubella, cytomegalovirus infection, lymphocytic choriomeningitis virus infection, herpes simplex virus infection). (See
         <a class="local">
          'Differential diagnosis'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/6011.html" rel="external">
          "Overview of TORCH infections"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A clinical geneticist to evaluate for other causes of microcephaly  (
         <a class="graphic graphic_table graphicRef61045" href="/z/d/graphic/61045.html" rel="external">
          table 4
         </a>
         ) and other anomalies, if present.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Early intervention and developmental specialists.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Supportive services for the family/caregivers.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Additional consultations may be warranted based on clinical findings:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Orthopedist, physiatrist, physical and/or occupational therapists for the management of hypertonia, club foot, and arthrogrypotic-like conditions (if present).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Lactation specialist, nutritionist, gastroenterologist, or speech or occupational therapist for management of feeding issues.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Endocrinologist for evaluation for hypothalamic, pituitary, and/or thyroid dysfunction.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Pulmonologist or otolaryngologist if there are concerns about aspiration.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cardiologist if there are features suggestive of cardiac disease (murmur, poor perfusion, cyanosis). The available data suggest that the prevalence of congenital heart disease is relatively high in infants with CZS (10 to 15 percent); however, hemodynamically significant cardiac defects are rare [
         <a href="#rid70">
          70,71
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/103723.html" rel="external">
          "Approach to the infant or child with a cardiac murmur"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5774.html" rel="external">
          "Identifying newborns with critical congenital heart disease"
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         For severely affected infants who are receiving palliative care, providers and families may choose to forego some of these consultations and evaluations.
        </p>
        <p class="headingAnchor" id="H3811030509">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         A definitive diagnosis of congenital Zika virus infection is confirmed by detection of Zika virus RNA by rRT-PCR in infant serum, urine, or cerebrospinal fluid collected within the first two days after birth [
         <a href="#rid76">
          76
         </a>
         ]. IgM antibodies may be positive or negative.
        </p>
        <p>
         A negative real-time reverse transcription polymerase chain reaction (rRT-PCR) result does not exclude congenital infection. A negative rRT-PCR result with positive Zika virus IgM test result indicates probable congenital Zika virus infection; however, false-positive results can occur from cross-reacting IgM antibodies or nonspecific reactivity [
         <a href="#rid84">
          84
         </a>
         ]. (See
         <a class="local">
          'Interpretation'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H3663795882">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis for congenital Zika virus infection includes other congenital infections and other causes of microcephaly.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Other congenital infections
         </strong>
         – The findings of congenital Zika infection (microcephaly, intracranial calcifications, ocular abnormalities, hearing loss, small for gestational age) could suggest other congenital infections, particularly rubella, cytomegalovirus, and toxoplasmosis. Other congenital infections may have characteristic clinical findings  (
         <a class="graphic graphic_table graphicRef76743" href="/z/d/graphic/76743.html" rel="external">
          table 5
         </a>
         ). In particular, hepatosplenomegaly, thrombocytopenia, and skin lesions are
         <strong>
          not
         </strong>
         typical of congenital Zika syndrome (although thrombocytopenia and rash have been reported with perinatal Zika infection) [
         <a href="#rid31">
          31,87
         </a>
         ]. Appropriate virologic and microbiologic studies generally are necessary to make a specific diagnosis. (See
         <a class="medical medical_review" href="/z/d/html/6011.html" rel="external">
          "Overview of TORCH infections"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Microcephaly
         </strong>
         – A variety of genetic abnormalities and environmental insults can affect brain development, resulting in microcephaly  (
         <a class="graphic graphic_table graphicRef75479" href="/z/d/graphic/75479.html" rel="external">
          table 6
         </a>
         ). The etiology and evaluation of microcephaly in infants is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/2839.html" rel="external">
          "Microcephaly in infants and children: Etiology and evaluation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1148167029">
         <span class="h1">
          MANAGEMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is no specific treatment for Zika virus infection and management is supportive. Management of the complications of congenital Zika syndrome is detailed in separate topic reviews:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Spasticity (see
         <a class="medical medical_review" href="/z/d/html/6176.html" rel="external">
          "Cerebral palsy: Overview of management and prognosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Feeding difficulties (see
         <a class="medical medical_review" href="/z/d/html/4976.html" rel="external">
          "Neonatal oral feeding difficulties due to sucking and swallowing disorders", section on 'Management approach'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hearing loss (see
         <a class="medical medical_review" href="/z/d/html/6298.html" rel="external">
          "Hearing loss in children: Treatment"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Seizures (see
         <a class="medical medical_review" href="/z/d/html/6201.html" rel="external">
          "Treatment of neonatal seizures"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H463703748">
         <span class="h1">
          FOLLOW-UP
         </span>
         <span class="headingEndMark">
          —
         </span>
         For infants with confirmed or probable congenital Zika infection, important aspects of follow-up care include  (
         <a class="graphic graphic_algorithm graphicRef109689" href="/z/d/graphic/109689.html" rel="external">
          algorithm 1
         </a>
         ) [
         <a href="#rid76">
          76
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A medical home should be established and visits with the primary care provider should occur monthly for at least the first six months after birth. Important aspects of follow-up include (see
         <a class="medical medical_review" href="/z/d/html/2840.html" rel="external">
          "Children and youth with special health care needs", section on 'Framework of care'
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Monitoring growth parameters, including head circumference (see
         <a class="medical medical_review" href="/z/d/html/2845.html" rel="external">
          "Normal growth patterns in infants and prepubertal children", section on 'Evaluation of growth'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Monitoring development using a standardized, validated developmental screening tool (see
         <a class="medical medical_review" href="/z/d/html/615.html" rel="external">
          "Developmental-behavioral surveillance and screening in primary care"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Providing routine immunizations (see
         <a class="medical medical_review" href="/z/d/html/2876.html" rel="external">
          "Standard immunizations for children and adolescents: Overview"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Providing anticipatory guidance, psychosocial support, and ensuring infants receive necessary testing and consultations
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If not performed during the birth hospitalization, auditory brainstem response testing and comprehensive ophthalmologic examination should be performed within one month after birth. The timing of follow-up eye examinations is based on the initial findings. (See
         <a class="medical medical_review" href="/z/d/html/4985.html" rel="external">
          "Screening the newborn for hearing loss", section on 'Automated auditory brainstem response'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6261.html" rel="external">
          "Vision screening and assessment in infants and children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If not performed during the birth hospitalization, the patient should be referred to a neurologist within one month after birth for comprehensive neurologic examination and determination of need for additional neuroimaging and/or electroencephalogram. The primary care provider should continue to monitor the neurologic examination closely as neurodevelopmental problems can develop later. (See
         <a class="medical medical_review" href="/z/d/html/15360.html" rel="external">
          "Detailed neurologic assessment of infants and children"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Referrals to a developmental specialist and for early intervention services should be made.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Infants should be monitored for other clinical features of congenital Zika syndrome that may develop or worsen over the first year after birth (eg, feeding difficulties, seizures, hydrocephalus):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Infant feedings should be monitored closely, and if there are signs of swallowing dysfunction (eg, prolonged feeding times, breathing difficulties, choking, or coughing with feeding), an assessment for dysphagia should be performed. (See
         <a class="medical medical_review" href="/z/d/html/14537.html" rel="external">
          "Aspiration due to swallowing dysfunction in children", section on 'Evaluation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Signs of increasing intracranial pressure (eg, increasing head circumference, irritability, or vomiting) should prompt neuroimaging to assess for postnatal hydrocephalus. (See
         <a class="medical medical_review" href="/z/d/html/110031.html" rel="external">
          "Hydrocephalus in children: Clinical features and diagnosis", section on 'Evaluation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Continued supportive services should be provided for the family/caregivers. For severely affected infants who are receiving palliative care, providers and families may choose to forego some of the above consultations and evaluations.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3825983279">
         <span class="h1">
          PROGNOSIS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Challenges in predicting long-term outcome
         </strong>
         – Outcomes for newborns with congenital Zika infection vary depending on the severity of initial findings. Newborns with severe findings of congenital Zika syndrome (CZS) in the newborn period (eg, severe microcephaly, refractory seizures, severe contractures, arthrogryposis) have the highest risk for mortality and long-term disability.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         However, normal findings at birth do not always predict normal outcome later in life. In one study, approximately 25 percent of patients who appeared asymptomatic at birth went on to have neurodevelopmental delays and/or abnormal hearing or ophthalmologic assessments on follow-up [
         <a href="#rid41">
          41
         </a>
         ]. Similarly, mild or subtle findings in the newborn period do not necessarily predict later neurodevelopmental outcomes [
         <a href="#rid41">
          41,50
         </a>
         ]. In the same study, approximately one-half of infants who had abnormal neurologic examination or abnormal neuroimaging findings at birth went on to have normal development on follow-up assessments in their second or third years of life [
         <a href="#rid41">
          41
         </a>
         ]. These findings underscore the need for long-term follow-up of all children with confirmed or suspected in utero Zika virus exposure. (See
         <a class="local">
          'Follow-up'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mortality
         </strong>
         – In a large Brazilian case series, the reported mortality rate among live-born infants with confirmed and probable congenital Zika infection ranged from 4 to 6 percent [
         <a href="#rid47">
          47
         </a>
         ]. In one study of 403 infants and children with confirmed or probable CZS who died in infancy or early childhood, most deaths (82 percent) occurred within the first 12 months after birth [
         <a href="#rid88">
          88
         </a>
         ]. Commonly reported causes of death included neonatal respiratory failure (12 percent), sepsis (11 percent), and multiple congenital malformations (5 percent).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neurodevelopmental impairment (NDI)
         </strong>
         –
         <strong>
         </strong>
         Long-term NDI is common in children with CZS, and may include cognitive impairment, motor impairment (eg, cerebral palsy [CP]), sensory impairment (blindness, hearing loss), and seizure disorders [
         <a href="#rid41">
          41,45,89-94
         </a>
         ]. Rates of NDI in the available reports vary considerably, likely due to differences in the definitions used for NDI and the population studied (some included all children with in utero Zika virus exposure, while others were limited to children diagnosed with CZS).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In a prospective study that followed children with in utero Zika virus exposure into the second and third years of life, nearly one-third of the children had developmental delay(s) and/or neurosensory abnormalities (abnormal eye examinations and/or hearing assessments) [
         <a href="#rid41">
          41
         </a>
         ]. In this study, 28 percent of children scored &lt;85 in at least one domain of the Bayley-III standardized developmental assessment, and 12 percent of children scored &lt;70. The most commonly affected domain was language function. Autism spectrum disorder was diagnosed in 2 percent of the children in this cohort.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         NDI is particularly common in children with Zika virus-associated microcephaly; however, NDI can occur among normocephalic children [
         <a href="#rid92">
          92,93,95
         </a>
         ]. In a study of 112 antenatally Zika virus-exposed children who were normocephalic at birth, 9 percent had severe developmental delay (ie, score &lt;70 on the Bayley-III) on testing performed at a mean age of 18 months [
         <a href="#rid92">
          92
         </a>
         ]. Language development was the most commonly affected domain. Infants who had auditory abnormalities identified in early screening hearing tests had higher rates of developmental delay, underscoring the adverse impact of Zika virus-induced hearing impairment on neurodevelopment. In the same cohort, smaller head circumference at birth, even if still within normal limits, was significantly associated with lower Bayley-III scores, highlighting that subtle clinical manifestations of Zika virus infection can identify infants who are at risk for neurodevelopmental delays [
         <a href="#rid95">
          95
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Motor impairment occurs primarily among infants who have manifestations of CZS at birth. The most severely affected infants have hypertonia and arthrogryposis in the newborn period. Motor abnormalities can also evolve during infancy and early childhood. In a study of 74 children with CZS without arthrogryposis or other congenital osteoarticular malformations in the newborn period who underwent follow-up neuromotor assessments at age 24 to 48 months, gross motor function was classified as mildly impaired in 8 percent, moderately impaired in 15 percent, and severely impaired in 77 percent [
         <a href="#rid91">
          91
         </a>
         ]. Although there were small developmental improvements detected in some patients, motor impairment in most children was consistent with severe CP. (See
         <a class="medical medical_review" href="/z/d/html/6167.html" rel="external">
          "Cerebral palsy: Classification and clinical features"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H16978875">
         <span class="h1">
          PERINATAL AND POSTNATAL INFECTION
         </span>
        </p>
        <p class="headingAnchor" id="H3390983950">
         <span class="h2">
          Perinatal exposure
         </span>
         <span class="headingEndMark">
          —
         </span>
         Maternal-fetal transmission of Zika virus can occur during labor and delivery. Two cases of intrapartum Zika virus transmission to infants from mothers infected within two to three days of delivery have been reported; one of these infants had no clinical manifestations, and the other had thrombocytopenia and a diffuse rash [
         <a href="#rid87">
          87,96
         </a>
         ]. There are no reports of Zika virus infection acquired by an infant at the time of delivery leading to microcephaly [
         <a href="#rid97">
          97
         </a>
         ]. Zika virus has been identified in breast milk; however, there are no conclusive data to determine whether transmission can occur via this route [
         <a href="#rid98">
          98
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/107211.html" rel="external">
          "Zika virus infection: Evaluation and management of pregnant patients", section on 'Breastfeeding'
         </a>
         .)
        </p>
        <p>
         Maternal and newborn laboratory testing is indicated during the first two weeks after birth if the mother had relevant epidemiologic exposure within two weeks of delivery and had ≥2 of the following manifestations of Zika virus infection: rash, conjunctivitis, arthralgia, or fever [
         <a href="#rid96">
          96
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If the mother and newborn present &lt;7 days after onset of maternal signs and symptoms, check serum and urine Zika virus RNA by real-time reverse transcription polymerase chain reaction (rRT-PCR) in both. If mother and newborn present 8 to 14 days after onset of symptoms, check urine Zika rRT-PCR in both. A positive maternal test is diagnostic of infection in the mother and confirms perinatal Zika virus exposure in the infant. A positive rRT-PCR test in the infant confirms infection of the infant.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If maternal rRT-PCR is negative and the mother is ≥4 days after the onset of symptoms, check Zika virus IgM and neutralizing antibody titers. A positive test indicates probable infection during pregnancy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If the newborn is symptomatic and the mother is asymptomatic, check maternal Zika virus IgM and neutralizing antibody titers.
        </p>
        <p>
        </p>
        <p>
         If newborn cerebrospinal fluid (CSF) is obtained for other reasons, CSF testing for Zika virus RNA (via rRT-PCR) is appropriate; however, concern for possible Zika exposure alone does not necessitate lumbar puncture [
         <a href="#rid96">
          96
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H116804916">
         <span class="h2">
          Postnatal infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infants and children who acquire Zika virus infection postnatally appear to have a mild course, similar to that in adults [
         <a href="#rid96">
          96,99
         </a>
         ]. Typical symptoms include fever, rash, and conjunctivitis. Zika virus infection in children is discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/106169.html" rel="external">
          "Zika virus infection: An overview", section on 'Children'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H226581187">
         <span class="h1">
          PREVENTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vaccines against Zika virus are in development but none are available for clinical use [
         <a href="#rid100">
          100,101
         </a>
         ]. Prevention efforts are aimed at reducing Zika infection during pregnancy, which is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/107211.html" rel="external">
          "Zika virus infection: Evaluation and management of pregnant patients", section on 'Prevention'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H421928255">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/110297.html" rel="external">
          "Society guideline links: Zika virus infection"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/118550.html" rel="external">
          "Society guideline links: Microcephaly"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/111578.html" rel="external">
          "Society guideline links: TORCH infections"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1075313229">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or email these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient education" and the keyword[s] of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topic (see
         <a class="medical medical_basics" href="/z/d/html/106290.html" rel="external">
          "Patient education: Zika virus infection (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3533210242">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Transmission
         </strong>
         – Vertical transmission of Zika virus from mother to fetus during pregnancy can be associated with serious sequelae in the fetus and newborn. The greatest risk appears to be with first- and second-trimester infection. (See
         <a class="medical medical_review" href="/z/d/html/107211.html" rel="external">
          "Zika virus infection: Evaluation and management of pregnant patients", section on 'Potential consequences of vertical transmission'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features
         </strong>
         – The clinical features of congenital Zika syndrome (CZS) include  (
         <a class="graphic graphic_table graphicRef110678" href="/z/d/graphic/110678.html" rel="external">
          table 1
         </a>
         and
         <a class="graphic graphic_picture graphicRef109690" href="/z/d/graphic/109690.html" rel="external">
          picture 1
         </a>
         ) (see
         <a class="local">
          'Clinical findings'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Microcephaly – While microcephaly is a key clinical finding; normal head circumference does not exclude CZS (see
         <a class="local">
          'Assessment for microcephaly'
         </a>
         above)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Craniofacial dysmorphisms (eg, craniofacial disproportion, craniosynostosis)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Neuromotor abnormalities (eg, hypertonia/spasticity, hyperreflexia, irritability)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Seizures
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Arthrogryposis
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Ocular abnormalities
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sensorineural hearing loss
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Neuroimaging abnormalities (eg, intracranial calcifications, ventriculomegaly) – Neuroradiologic abnormalities are detected in the most infants with CZS who undergo neuroimaging  (
         <a class="graphic graphic_diagnosticimage graphicRef109691 graphicRef109692 graphicRef126225" href="/z/d/graphic/109691.html" rel="external">
          image 1A-C
         </a>
         ) (see
         <a class="local">
          'Neuroimaging findings'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation
         </strong>
         – For all infants with suspected or possible congenital Zika virus infection, the initial evaluation includes
         <strong>
          all
         </strong>
         of the following  (
         <a class="graphic graphic_algorithm graphicRef109689" href="/z/d/graphic/109689.html" rel="external">
          algorithm 1
         </a>
         ) (see
         <a class="local">
          'Evaluation'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         A thorough physical examination (with measurement of head [occipitofrontal] circumference, length, and weight; assessment of gestational age; and examination for neurologic abnormalities and dysmorphic features) (see
         <a class="local">
          'Assessment for microcephaly'
         </a>
         above and
         <a class="local">
          'Findings in the newborn'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Laboratory testing for Zika virus infection, which includes the following (see
         <a class="local">
          'Laboratory evaluation'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Serum and urine for Zika virus RNA via real-time reverse transcription polymerase chain reaction (rRT-PCR).
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Serum Zika virus immunoglobulin M (IgM) enzyme-linked immunosorbent assay. If IgM is positive with negative rRT-PCR, neutralization tests are used to confirm the specificity of the antibodies against Zika virus and to exclude a false-positive IgM result. (See
         <a class="local">
          'Excluding false positive IgM results'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         If cerebrospinal fluid (CSF) is available, test CSF for Zika virus RNA (via rRT-PCR) and Zika virus IgM. CSF specimens need not be collected for the sole purpose of Zika virus testing but may be reasonable for evaluation of infants with microcephaly or intracranial calcifications.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Head ultrasonography (see
         <a class="local">
          'Neuroimaging'
         </a>
         above)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Standard newborn hearing assessment (see
         <a class="medical medical_review" href="/z/d/html/4985.html" rel="external">
          "Screening the newborn for hearing loss"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Additional evaluation
         </strong>
         – Infants with positive maternal laboratory testing for Zika virus
         <strong>
          and
         </strong>
         clinical evidence of CZS should undergo comprehensive evaluation, including ophthalmologic examination, laboratory tests, and specialist consultation  (
         <a class="graphic graphic_algorithm graphicRef109689" href="/z/d/graphic/109689.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="local">
          'Additional evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Diagnosis
         </strong>
         – A definitive diagnosis of congenital Zika virus infection is confirmed by detection of Zika virus RNA by rRT-PCR in samples of serum, urine, or CSF collected within the first few days of life; IgM antibodies may be positive or negative. A negative rRT-PCR result with positive Zika virus IgM test result indicates probable congenital Zika virus infection  (
         <a class="graphic graphic_table graphicRef115662" href="/z/d/graphic/115662.html" rel="external">
          table 3
         </a>
         ). (See
         <a class="local">
          'Diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Differential diagnosis
         </strong>
         – The differential diagnosis for congenital Zika virus infection includes other congenital infections  (
         <a class="graphic graphic_table graphicRef76743" href="/z/d/graphic/76743.html" rel="external">
          table 5
         </a>
         ) and other causes of microcephaly  (
         <a class="graphic graphic_table graphicRef75479" href="/z/d/graphic/75479.html" rel="external">
          table 6
         </a>
         ). (See
         <a class="local">
          'Differential diagnosis'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/6011.html" rel="external">
          "Overview of TORCH infections"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2839.html" rel="external">
          "Microcephaly in infants and children: Etiology and evaluation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management
         </strong>
         – There is no specific treatment for Zika virus infection and management is supportive. Prevention efforts are aimed at reducing Zika infection during pregnancy. (See
         <a class="local">
          'Management'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/107211.html" rel="external">
          "Zika virus infection: Evaluation and management of pregnant patients", section on 'Prevention'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Follow-up
         </strong>
         – For infants with confirmed or probable Zika virus infection, close follow-up is necessary. The appropriate follow-up evaluation depends upon the clinical findings. All infants should have close monitoring of growth and development  (
         <a class="graphic graphic_algorithm graphicRef109689" href="/z/d/graphic/109689.html" rel="external">
          algorithm 1
         </a>
         ). (See
         <a class="local">
          'Follow-up'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prognosis
         </strong>
         – Outcomes for newborns with congenital Zika infection vary depending on the severity of initial findings. Reported mortality rates among live-born infants range from 4 to 6 percent. Long-term neurodevelopmental impairments are common in children with CZS, and may include cognitive impairment, motor impairment (eg, cerebral palsy [CP]), sensory impairment (blindness, hearing loss), and seizure disorders. (See
         <a class="local">
          'Prognosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Perinatal and postnatal infection
         </strong>
         – Maternal-fetal transmission of Zika virus can occur during labor and delivery. There are no reports of Zika virus infection acquired by an infant at the time of delivery leading to microcephaly. There are no data to contraindicate breastfeeding, although the virus has been identified in breast milk. Maternal and newborn laboratory testing is indicated during the first two weeks of life if the mother had relevant epidemiologic exposure within two weeks of delivery and had clinical manifestations of Zika virus infection (eg, rash, conjunctivitis, arthralgia, or fever). Infants and children who acquire Zika virus infection postnatally appear to have a mild course, similar to that seen in adults. (See
         <a class="local">
          'Perinatal and postnatal infection'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Costello A, Dua T, Duran P, et al. Defining the syndrome associated with congenital Zika virus infection. Bull World Health Organ 2016; 94:406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miner JJ, Cao B, Govero J, et al. Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise. Cell 2016; 165:1081.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tabata T, Petitt M, Puerta-Guardo H, et al. Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission. Cell Host Microbe 2016; 20:155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cugola FR, Fernandes IR, Russo FB, et al. The Brazilian Zika virus strain causes birth defects in experimental models. Nature 2016; 534:267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vouga M, Baud D. Imaging of congenital Zika virus infection: the route to identification of prognostic factors. Prenat Diagn 2016; 36:799.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jurado KA, Simoni MK, Tang Z, et al. Zika virus productively infects primary human placenta-specific macrophages. JCI Insight 2016; 1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garcez PP, Loiola EC, Madeiro da Costa R, et al. Zika virus impairs growth in human neurospheres and brain organoids. Science 2016; 352:816.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quicke KM, Bowen JR, Johnson EL, et al. Zika Virus Infects Human Placental Macrophages. Cell Host Microbe 2016; 20:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rosenberg AZ, Yu W, Hill DA, et al. Placental Pathology of Zika Virus: Viral Infection of the Placenta Induces Villous Stromal Macrophage (Hofbauer Cell) Proliferation and Hyperplasia. Arch Pathol Lab Med 2017; 141:43.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brasil P, Pereira JP Jr, Moreira ME, et al. Zika Virus Infection in Pregnant Women in Rio de Janeiro. N Engl J Med 2016; 375:2321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martines RB, Bhatnagar J, de Oliveira Ramos AM, et al. Pathology of congenital Zika syndrome in Brazil: a case series. Lancet 2016; 388:898.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hazin AN, Poretti A, Di Cavalcanti Souza Cruz D, et al. Computed Tomographic Findings in Microcephaly Associated with Zika Virus. N Engl J Med 2016; 374:2193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tang H, Hammack C, Ogden SC, et al. Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth. Cell Stem Cell 2016; 18:587.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gilmore EC, Walsh CA. Genetic causes of microcephaly and lessons for neuronal development. Wiley Interdiscip Rev Dev Biol 2013; 2:461.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Driggers RW, Ho CY, Korhonen EM, et al. Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities. N Engl J Med 2016; 374:2142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mlakar J, Korva M, Tul N, et al. Zika Virus Associated with Microcephaly. N Engl J Med 2016; 374:951.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schuler-Faccini L, Ribeiro EM, Feitosa IM, et al. Possible Association Between Zika Virus Infection and Microcephaly - Brazil, 2015. MMWR Morb Mortal Wkly Rep 2016; 65:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martines RB, Bhatnagar J, Keating MK, et al. Notes from the Field: Evidence of Zika Virus Infection in Brain and Placental Tissues from Two Congenitally Infected Newborns and Two Fetal Losses--Brazil, 2015. MMWR Morb Mortal Wkly Rep 2016; 65:159.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Calvet G, Aguiar RS, Melo AS, et al. Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study. Lancet Infect Dis 2016; 16:653.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Microcephaly Epidemic Research Group1. Microcephaly in Infants, Pernambuco State, Brazil, 2015. Emerg Infect Dis 2016; 22:1090.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarno M, Sacramento GA, Khouri R, et al. Zika Virus Infection and Stillbirths: A Case of Hydrops Fetalis, Hydranencephaly and Fetal Demise. PLoS Negl Trop Dis 2016; 10:e0004517.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Fatima Vasco Aragao M, van der Linden V, Brainer-Lima AM, et al. Clinical features and neuroimaging (CT and MRI) findings in presumed Zika virus related congenital infection and microcephaly: retrospective case series study. BMJ 2016; 353:i1901.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pomar L, Vouga M, Lambert V, et al. Maternal-fetal transmission and adverse perinatal outcomes in pregnant women infected with Zika virus: prospective cohort study in French Guiana. BMJ 2018; 363:k4431.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Honein MA, Dawson AL, Petersen EE, et al. Birth Defects Among Fetuses and Infants of US Women With Evidence of Possible Zika Virus Infection During Pregnancy. JAMA 2017; 317:59.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reynolds MR, Jones AM, Petersen EE, et al. Vital Signs: Update on Zika Virus-Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure - U.S. Zika Pregnancy Registry, 2016. MMWR Morb Mortal Wkly Rep 2017; 66:366.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hoen B, Schaub B, Funk AL, et al. Pregnancy Outcomes after ZIKV Infection in French Territories in the Americas. N Engl J Med 2018; 378:985.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rice ME, Galang RR, Roth NM, et al. Vital Signs: Zika-Associated Birth Defects and Neurodevelopmental Abnormalities Possibly Associated with Congenital Zika Virus Infection - U.S. Territories and Freely Associated States, 2018. MMWR Morb Mortal Wkly Rep 2018; 67:858.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ximenes RAA, Miranda-Filho DB, Brickley EB, et al. Risk of adverse outcomes in offspring with RT-PCR confirmed prenatal Zika virus exposure: An individual participant data meta-analysis of 13 cohorts in the Zika Brazilian Cohorts Consortium. Lancet Reg Health Am 2022.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roth NM, Reynolds MR, Lewis EL, et al. Zika-Associated Birth Defects Reported in Pregnancies with Laboratory Evidence of Confirmed or Possible Zika Virus Infection - U.S. Zika Pregnancy and Infant Registry, December 1, 2015-March 31, 2018. MMWR Morb Mortal Wkly Rep 2022; 71:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cauchemez S, Besnard M, Bompard P, et al. Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study. Lancet 2016; 387:2125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miranda-Filho Dde B, Martelli CM, Ximenes RA, et al. Initial Description of the Presumed Congenital Zika Syndrome. Am J Public Health 2016; 106:598.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meneses JDA, Ishigami AC, de Mello LM, et al. Lessons Learned at the Epicenter of Brazil's Congenital Zika Epidemic: Evidence From 87 Confirmed Cases. Clin Infect Dis 2017; 64:1302.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moore CA, Staples JE, Dobyns WB, et al. Characterizing the Pattern of Anomalies in Congenital Zika Syndrome for Pediatric Clinicians. JAMA Pediatr 2017; 171:288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rasmussen SA, Jamieson DJ, Honein MA, Petersen LR. Zika Virus and Birth Defects--Reviewing the Evidence for Causality. N Engl J Med 2016; 374:1981.
          </a>
         </li>
         <li class="breakAll">
          World Health Organization. Zika virus and complications: Questions and answers. http://www.who.int/features/qa/zika/en/ (Accessed on April 19, 2016).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cordeiro MT, Pena LJ, Brito CA, et al. Positive IgM for Zika virus in the cerebrospinal fluid of 30 neonates with microcephaly in Brazil. Lancet 2016; 387:1811.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Araújo TVB, Rodrigues LC, de Alencar Ximenes RA, et al. Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study. Lancet Infect Dis 2016; 16:1356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cuevas EL, Tong VT, Rozo N, et al. Preliminary Report of Microcephaly Potentially Associated with Zika Virus Infection During Pregnancy - Colombia, January-November 2016. MMWR Morb Mortal Wkly Rep 2016; 65:1409.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ventura CV, Maia M, Dias N, et al. Zika: neurological and ocular findings in infant without microcephaly. Lancet 2016; 387:2502.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van der Linden V, Pessoa A, Dobyns W, et al. Description of 13 Infants Born During October 2015-January 2016 With Congenital Zika Virus Infection Without Microcephaly at Birth - Brazil. MMWR Morb Mortal Wkly Rep 2016; 65:1343.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nielsen-Saines K, Brasil P, Kerin T, et al. Delayed childhood neurodevelopment and neurosensory alterations in the second year of life in a prospective cohort of ZIKV-exposed children. Nat Med 2019; 25:1213.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adachi K, Romero T, Nielsen-Saines K, et al. Early Clinical Infancy Outcomes for Microcephaly and/or Small for Gestational Age Zika-Exposed Infants. Clin Infect Dis 2020; 70:2663.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pool KL, Adachi K, Karnezis S, et al. Association Between Neonatal Neuroimaging and Clinical Outcomes in Zika-Exposed Infants From Rio de Janeiro, Brazil. JAMA Netw Open 2019; 2:e198124.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alves LV, Mello MJG, Bezerra PG, Alves JGB. Congenital Zika Syndrome and Infantile Spasms: Case Series Study. J Child Neurol 2018; 33:664.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Maia CQ, Lima WG, Nizer WSDC, Ferreira JMS. Epilepsy in children with Congenital Zika Syndrome: A systematic review and meta-analysis. Epilepsia 2021; 62:1193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carvalho MDCG, Ximenes RAA, Montarroyos UR, et al. Early epilepsy in children with Zika-related microcephaly in a cohort in Recife, Brazil: Characteristics, electroencephalographic findings, and treatment response. Epilepsia 2020; 61:509.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           França GV, Schuler-Faccini L, Oliveira WK, et al. Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation. Lancet 2016; 388:891.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van der Linden V, Filho EL, Lins OG, et al. Congenital Zika syndrome with arthrogryposis: retrospective case series study. BMJ 2016; 354:i3899.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pone MVDS, Gomes da Silva TO, Ribeiro CTM, et al. Acquired Hip Dysplasia in Children with Congenital Zika Virus Infection in the First Four Years of Life. Viruses 2022; 14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lopes Moreira ME, Nielsen-Saines K, Brasil P, et al. Neurodevelopment in Infants Exposed to Zika Virus In Utero. N Engl J Med 2018; 379:2377.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ximenes RAA, Miranda-Filho DB, Brickley EB, et al. Risk of adverse outcomes in offspring with RT-PCR confirmed prenatal Zika virus exposure: An individual participant data meta-analysis of 13 cohorts in the Zika Brazilian Cohorts Consortium. Lancet Reg Health Am 2022; 100395.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsui I, Moreira MEL, Rossetto JD, et al. Eye Findings in Infants With Suspected or Confirmed Antenatal Zika Virus Exposure. Pediatrics 2018; 142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zin AA, Tsui I, Rossetto J, et al. Screening Criteria for Ophthalmic Manifestations of Congenital Zika Virus Infection. JAMA Pediatr 2017; 171:847.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Paula Freitas B, de Oliveira Dias JR, Prazeres J, et al. Ocular Findings in Infants With Microcephaly Associated With Presumed Zika Virus Congenital Infection in Salvador, Brazil. JAMA Ophthalmol 2016.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moshfeghi DM, de Miranda HA 2nd, Costa MC. Zika Virus, Microcephaly, and Ocular Findings. JAMA Ophthalmol 2016; 134:945.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ventura CV, Maia M, Travassos SB, et al. Risk Factors Associated With the Ophthalmoscopic Findings Identified in Infants With Presumed Zika Virus Congenital Infection. JAMA Ophthalmol 2016; 134:912.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miranda HA 2nd, Costa MC, Frazão MAM, et al. Expanded Spectrum of Congenital Ocular Findings in Microcephaly with Presumed Zika Infection. Ophthalmology 2016; 123:1788.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Oliveira Dias JR, Ventura CV, Borba PD, et al. INFANTS WITH CONGENITAL ZIKA SYNDROME AND OCULAR FINDINGS FROM SÃO PAULO, BRAZIL: SPREAD OF INFECTION. Retin Cases Brief Rep 2018; 12:382.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ventura LO, Ventura CV, Lawrence L, et al. Visual impairment in children with congenital Zika syndrome. J AAPOS 2017; 21:295.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ventura CV, Ventura LO, Bravo-Filho V, et al. Optical Coherence Tomography of Retinal Lesions in Infants With Congenital Zika Syndrome. JAMA Ophthalmol 2016; 134:1420.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ventura CV, Maia M, Bravo-Filho V, et al. Zika virus in Brazil and macular atrophy in a child with microcephaly. Lancet 2016; 387:228.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ventura CV, Maia M, Ventura BV, et al. Ophthalmological findings in infants with microcephaly and presumable intra-uterus Zika virus infection. Arq Bras Oftalmol 2016; 79:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Paula Freitas B, Ko AI, Khouri R, et al. Glaucoma and Congenital Zika Syndrome. Ophthalmology 2017; 124:407.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oliveira Melo AS, Malinger G, Ximenes R, et al. Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg? Ultrasound Obstet Gynecol 2016; 47:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yepez JB, Murati FA, Pettito M, et al. Ophthalmic Manifestations of Congenital Zika Syndrome in Colombia and Venezuela. JAMA Ophthalmol 2017; 135:440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ventura LO, Ventura CV, Dias NC, et al. Visual impairment evaluation in 119 children with congenital Zika syndrome. J AAPOS 2018; 22:218.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verçosa I, Carneiro P, Verçosa R, et al. The visual system in infants with microcephaly related to presumed congenital Zika syndrome. J AAPOS 2017; 21:300.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zin AA, Tsui I, Rossetto JD, et al. Visual function in infants with antenatal Zika virus exposure. J AAPOS 2018; 22:452.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leal MC, Muniz LF, Ferreira TS, et al. Hearing Loss in Infants with Microcephaly and Evidence of Congenital Zika Virus Infection - Brazil, November 2015-May 2016. MMWR Morb Mortal Wkly Rep 2016; 65:917.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cavalcanti DD, Alves LV, Furtado GJ, et al. Echocardiographic findings in infants with presumed congenital Zika syndrome: Retrospective case series study. PLoS One 2017; 12:e0175065.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Orofino DHG, Passos SRL, de Oliveira RVC, et al. Cardiac findings in infants with in utero exposure to Zika virus- a cross sectional study. PLoS Negl Trop Dis 2018; 12:e0006362.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Besnard M, Eyrolle-Guignot D, Guillemette-Artur P, et al. Congenital cerebral malformations and dysfunction in fetuses and newborns following the 2013 to 2014 Zika virus epidemic in French Polynesia. Euro Surveill 2016; 21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Soares de Oliveira-Szejnfeld P, Levine D, Melo AS, et al. Congenital Brain Abnormalities and Zika Virus: What the Radiologist Can Expect to See Prenatally and Postnatally. Radiology 2016; 281:203.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Culjat M, Darling SE, Nerurkar VR, et al. Clinical and Imaging Findings in an Infant With Zika Embryopathy. Clin Infect Dis 2016; 63:805.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Petribu NCL, Aragao MFV, van der Linden V, et al. Follow-up brain imaging of 37 children with congenital Zika syndrome: case series study. BMJ 2017; 359:j4188.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Adebanjo T, Godfred-Cato S, Viens L, et al. Update: Interim Guidance for the Diagnosis, Evaluation, and Management of Infants with Possible Congenital Zika Virus Infection - United States, October 2017. MMWR Morb Mortal Wkly Rep 2017; 66:1089.
          </a>
         </li>
         <li class="breakAll">
          World Health Organization rapid advice guideline. Screening, assessment and management of neonates and infants with complications associated with Zika virus exposure in utero. Available at: http://apps.who.int/iris/bitstream/10665/204475/1/WHO_ZIKV_MOC_16.3_eng.pdf?ua=1 (Accessed on August 30, 2016).
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. Congenital Microcephaly Case Definitions. http://www.cdc.gov/zika/public-health-partners/microcephaly-case-definitions.html (Accessed on April 04, 2016).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Villar J, Cheikh Ismail L, Victora CG, et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project. Lancet 2014; 384:857.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Petersen LR, Jamieson DJ, Honein MA. Zika Virus. N Engl J Med 2016; 375:294.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roth NM, Woodworth KR, Godfred-Cato S, et al. Identifying possible inaccuracy in reported birth head circumference measurements among infants in the US Zika Pregnancy and Infant Registry. Birth Defects Res 2022; 114:314.
          </a>
         </li>
         <li class="breakAll">
          American Academy of Pediatrics. Zika. In: Red Book: 2018 Report of the Committee on Infectious Diseases, 31st Ed, Kimberlin DW, Brady MT, Jackson MA, Long SS (Eds), American Academy of Pediatrics, Itasca, IL 2018. p.894.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brasil P, Vasconcelos Z, Kerin T, et al. Zika virus vertical transmission in children with confirmed antenatal exposure. Nat Commun 2020; 11:3510.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rabe IB, Staples JE, Villanueva J, et al. Interim Guidance for Interpretation of Zika Virus Antibody Test Results. MMWR Morb Mortal Wkly Rep 2016; 65:543.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oliveira DB, Almeida FJ, Durigon EL, et al. Prolonged Shedding of Zika Virus Associated with Congenital Infection. N Engl J Med 2016; 375:1202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Espindola OM, Jaenisch T, Nielsen-Saines K, et al. ZIKA Virus Neutralizing Antibody Kinetics in Antenatally Exposed Infants. J Infect Dis 2021; 224:1060.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Besnard M, Lastere S, Teissier A, et al. Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Euro Surveill 2014; 19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Costa MDCN, Cardim LL, Moore CA, et al. Causes of death in children with congenital Zika syndrome in Brazil, 2015 to 2018: A nationwide record linkage study. PLoS Med 2023; 20:e1004181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gordon-Lipkin E, Peacock G. The Spectrum of Developmental Disability with Zika Exposure: What Is Known, What Is Unknown, and Implications for Clinicians. J Dev Behav Pediatr 2019; 40:387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marbán-Castro E, Vazquez Guillamet LJ, Pantoja PE, et al. Neurodevelopment in Normocephalic Children Exposed to Zika Virus in Utero with No Observable Defects at Birth: A Systematic Review with Meta-Analysis. Int J Environ Res Public Health 2022; 19.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hamanaka T, Ribeiro CTM, Pone S, et al. Longitudinal Follow-Up of Gross Motor Function in Children with Congenital Zika Virus Syndrome from a Cohort in Rio de Janeiro, Brazil. Viruses 2022; 14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tiene SF, Cranston JS, Nielsen-Saines K, et al. Early Predictors of Poor Neurologic Outcomes in a Prospective Cohort of Infants With Antenatal Exposure to Zika Virus. Pediatr Infect Dis J 2022; 41:255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aizawa CYP, Caron DMR, Souza CB, et al. Neurodevelopment in the third year of life in children with antenatal ZIKV-exposure. Rev Saude Publica 2021; 55:15.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marques FJP, Amarante C, Elias MAC, et al. Neurodevelopmental outcomes in a cohort of children with congenital Zika syndrome at 12 and 24 months of age. Child Care Health Dev 2023; 49:304.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cranston JS, Tiene SF, Nielsen-Saines K, et al. Association Between Antenatal Exposure to Zika Virus and Anatomical and Neurodevelopmental Abnormalities in Children. JAMA Netw Open 2020; 3:e209303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fleming-Dutra KE, Nelson JM, Fischer M, et al. Update: Interim Guidelines for Health Care Providers Caring for Infants and Children with Possible Zika Virus Infection--United States, February 2016. MMWR Morb Mortal Wkly Rep 2016; 65:182.
          </a>
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. Questions and Answers for Healthcare Providers Caring for Infants and Children with Possible Zika Virus Infection. http://www.cdc.gov/zika/hc-providers/qa-pediatrician.html (Accessed on February 22, 2016).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Colt S, Garcia-Casal MN, Peña-Rosas JP, et al. Transmission of Zika virus through breast milk and other breastfeeding-related bodily-fluids: A systematic review. PLoS Negl Trop Dis 2017; 11:e0005528.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Read JS, Torres-Velasquez B, Lorenzi O, et al. Symptomatic Zika Virus Infection in Infants, Children, and Adolescents Living in Puerto Rico. JAMA Pediatr 2018; 172:686.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Acosta CJ, Diaz C, Nordio F, et al. Persistence of Immunogenicity of a Purified Inactivated Zika Virus Vaccine Candidate in Healthy Adults: 2 Years of Follow-up Compared With Natural Infection. J Infect Dis 2023; 227:1303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yeasmin M, Molla MMA, Masud HMAA, Saif-Ur-Rahman KM. Safety and immunogenicity of Zika virus vaccine: A systematic review of clinical trials. Rev Med Virol 2023; 33:e2385.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 109681 Version 36.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27274588" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Defining the syndrome associated with congenital Zika virus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27180225" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27443522" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27279226" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : The Brazilian Zika virus strain causes birth defects in experimental models.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27481629" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Imaging of congenital Zika virus infection: the route to identification of prognostic factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27595140" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Zika virus productively infects primary human placenta-specific macrophages.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27064148" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Zika virus impairs growth in human neurospheres and brain organoids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27247001" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Zika Virus Infects Human Placental Macrophages.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27681334" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Placental Pathology of Zika Virus: Viral Infection of the Placenta Induces Villous Stromal Macrophage (Hofbauer Cell) Proliferation and Hyperplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26943629" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Zika Virus Infection in Pregnant Women in Rio de Janeiro.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27372395" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Pathology of congenital Zika syndrome in Brazil: a case series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27050112" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Computed Tomographic Findings in Microcephaly Associated with Zika Virus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26952870" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Zika Virus Infects Human Cortical Neural Progenitors and Attenuates Their Growth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24014418" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Genetic causes of microcephaly and lessons for neuronal development.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27028667" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26862926" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Zika Virus Associated with Microcephaly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26820244" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Possible Association Between Zika Virus Infection and Microcephaly - Brazil, 2015.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26890059" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Notes from the Field: Evidence of Zika Virus Infection in Brain and Placental Tissues from Two Congenitally Infected Newborns and Two Fetal Losses--Brazil, 2015.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26897108" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Detection and sequencing of Zika virus from amniotic fluid of fetuses with microcephaly in Brazil: a case study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27071041" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Microcephaly in Infants, Pernambuco State, Brazil, 2015.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26914330" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Zika Virus Infection and Stillbirths: A Case of Hydrops Fetalis, Hydranencephaly and Fetal Demise.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27075009" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Clinical features and neuroimaging (CT and MRI) findings in presumed Zika virus related congenital infection and microcephaly: retrospective case series study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30381296" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Maternal-fetal transmission and adverse perinatal outcomes in pregnant women infected with Zika virus: prospective cohort study in French Guiana.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27960197" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Birth Defects Among Fetuses and Infants of US Women With Evidence of Possible Zika Virus Infection During Pregnancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28384133" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Vital Signs: Update on Zika Virus-Associated Birth Defects and Evaluation of All U.S. Infants with Congenital Zika Virus Exposure - U.S. Zika Pregnancy Registry, 2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29539287" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Pregnancy Outcomes after ZIKV Infection in French Territories in the Americas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30091967" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Vital Signs: Zika-Associated Birth Defects and Neurodevelopmental Abnormalities Possibly Associated with Congenital Zika Virus Infection - U.S. Territories and Freely Associated States, 2018.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Risk of adverse outcomes in offspring with RT-PCR confirmed prenatal Zika virus exposure: An individual participant data meta-analysis of 13 cohorts in the Zika Brazilian Cohorts Consortium
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35051132" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Zika-Associated Birth Defects Reported in Pregnancies with Laboratory Evidence of Confirmed or Possible Zika Virus Infection - U.S. Zika Pregnancy and Infant Registry, December 1, 2015-March 31, 2018.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26993883" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Association between Zika virus and microcephaly in French Polynesia, 2013-15: a retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26959258" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Initial Description of the Presumed Congenital Zika Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28329257" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Lessons Learned at the Epicenter of Brazil's Congenital Zika Epidemic: Evidence From 87 Confirmed Cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27812690" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Characterizing the Pattern of Anomalies in Congenital Zika Syndrome for Pediatric Clinicians.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27074377" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Zika Virus and Birth Defects--Reviewing the Evidence for Causality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27074377" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Zika Virus and Birth Defects--Reviewing the Evidence for Causality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27103126" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Positive IgM for Zika virus in the cerebrospinal fluid of 30 neonates with microcephaly in Brazil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27641777" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27977645" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Preliminary Report of Microcephaly Potentially Associated with Zika Virus Infection During Pregnancy - Colombia, January-November 2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27287830" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Zika: neurological and ocular findings in infant without microcephaly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27906905" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Description of 13 Infants Born During October 2015-January 2016 With Congenital Zika Virus Infection Without Microcephaly at Birth - Brazil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31285631" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Delayed childhood neurodevelopment and neurosensory alterations in the second year of life in a prospective cohort of ZIKV-exposed children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31346616" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Early Clinical Infancy Outcomes for Microcephaly and/or Small for Gestational Age Zika-Exposed Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31365112" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Association Between Neonatal Neuroimaging and Clinical Outcomes in Zika-Exposed Infants From Rio de Janeiro, Brazil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29897010" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Congenital Zika Syndrome and Infantile Spasms: Case Series Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33778951" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Epilepsy in children with Congenital Zika Syndrome: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32065676" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Early epilepsy in children with Zika-related microcephaly in a cohort in Recife, Brazil: Characteristics, electroencephalographic findings, and treatment response.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27372398" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Congenital Zika virus syndrome in Brazil: a case series of the first 1501 livebirths with complete investigation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27509902" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Congenital Zika syndrome with arthrogryposis: retrospective case series study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36560649" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Acquired Hip Dysplasia in Children with Congenital Zika Virus Infection in the First Four Years of Life.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30575464" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Neurodevelopment in Infants Exposed to Zika Virus In Utero.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Risk of adverse outcomes in offspring with RT-PCR confirmed prenatal Zika virus exposure: An individual participant data meta-analysis of 13 cohorts in the Zika Brazilian Cohorts Consortium
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30213843" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Eye Findings in Infants With Suspected or Confirmed Antenatal Zika Virus Exposure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28715527" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Screening Criteria for Ophthalmic Manifestations of Congenital Zika Virus Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26865554" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Ocular Findings in Infants With Microcephaly Associated With Presumed Zika Virus Congenital Infection in Salvador, Brazil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27254835" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Zika Virus, Microcephaly, and Ocular Findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27228275" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Risk Factors Associated With the Ophthalmoscopic Findings Identified in Infants With Presumed Zika Virus Congenital Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27236271" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Expanded Spectrum of Congenital Ocular Findings in Microcephaly with Presumed Zika Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28060137" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : INFANTS WITH CONGENITAL ZIKA SYNDROME AND OCULAR FINDINGS FROM SÃO PAULO, BRAZIL: SPREAD OF INFECTION.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28450178" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Visual impairment in children with congenital Zika syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27832267" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Optical Coherence Tomography of Retinal Lesions in Infants With Congenital Zika Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26775125" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Zika virus in Brazil and macular atrophy in a child with microcephaly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26840156" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Ophthalmological findings in infants with microcephaly and presumable intra-uterus Zika virus infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27914834" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Glaucoma and Congenital Zika Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26731034" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28418539" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Ophthalmic Manifestations of Congenital Zika Syndrome in Colombia and Venezuela.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29654909" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Visual impairment evaluation in 119 children with congenital Zika syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28652051" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : The visual system in infants with microcephaly related to presumed congenital Zika syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30359768" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Visual function in infants with antenatal Zika virus exposure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27585248" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Hearing Loss in Infants with Microcephaly and Evidence of Congenital Zika Virus Infection - Brazil, November 2015-May 2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28426680" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Echocardiographic findings in infants with presumed congenital Zika syndrome: Retrospective case series study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29579059" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Cardiac findings in infants with in utero exposure to Zika virus- a cross sectional study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27063794" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Congenital cerebral malformations and dysfunction in fetuses and newborns following the 2013 to 2014 Zika virus epidemic in French Polynesia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27552432" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Congenital Brain Abnormalities and Zika Virus: What the Radiologist Can Expect to See Prenatally and Postnatally.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27193747" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Clinical and Imaging Findings in an Infant With Zika Embryopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29030384" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Follow-up brain imaging of 37 children with congenital Zika syndrome: case series study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29049277" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Update: Interim Guidance for the Diagnosis, Evaluation, and Management of Infants with Possible Congenital Zika Virus Infection - United States, October 2017.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29049277" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Update: Interim Guidance for the Diagnosis, Evaluation, and Management of Infants with Possible Congenital Zika Virus Infection - United States, October 2017.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29049277" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Update: Interim Guidance for the Diagnosis, Evaluation, and Management of Infants with Possible Congenital Zika Virus Infection - United States, October 2017.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25209487" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27355409" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Zika Virus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35332688" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Identifying possible inaccuracy in reported birth head circumference measurements among infants in the US Zika Pregnancy and Infant Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35332688" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Identifying possible inaccuracy in reported birth head circumference measurements among infants in the US Zika Pregnancy and Infant Registry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32665616" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Zika virus vertical transmission in children with confirmed antenatal exposure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27254248" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Interim Guidance for Interpretation of Zika Virus Antibody Test Results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27653589" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Prolonged Shedding of Zika Virus Associated with Congenital Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33528564" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : ZIKA Virus Neutralizing Antibody Kinetics in Antenatally Exposed Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24721538" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36827251" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Causes of death in children with congenital Zika syndrome in Brazil, 2015 to 2018: A nationwide record linkage study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30921103" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : The Spectrum of Developmental Disability with Zika Exposure: What Is Known, What Is Unknown, and Implications for Clinicians.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35742566" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Neurodevelopment in Normocephalic Children Exposed to Zika Virus in Utero with No Observable Defects at Birth: A Systematic Review with Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35746646" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Longitudinal Follow-Up of Gross Motor Function in Children with Congenital Zika Virus Syndrome from a Cohort in Rio de Janeiro, Brazil.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35144270" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Early Predictors of Poor Neurologic Outcomes in a Prospective Cohort of Infants With Antenatal Exposure to Zika Virus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33909869" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Neurodevelopment in the third year of life in children with antenatal ZIKV-exposure.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35959569" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Neurodevelopmental outcomes in a cohort of children with congenital Zika syndrome at 12 and 24 months of age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32633763" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Association Between Antenatal Exposure to Zika Virus and Anatomical and Neurodevelopmental Abnormalities in Children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26914500" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Update: Interim Guidelines for Health Care Providers Caring for Infants and Children with Possible Zika Virus Infection--United States, February 2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26914500" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Update: Interim Guidelines for Health Care Providers Caring for Infants and Children with Possible Zika Virus Infection--United States, February 2016.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28394887" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Transmission of Zika virus through breast milk and other breastfeeding-related bodily-fluids: A systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29813148" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Symptomatic Zika Virus Infection in Infants, Children, and Adolescents Living in Puerto Rico.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36484441" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Persistence of Immunogenicity of a Purified Inactivated Zika Virus Vaccine Candidate in Healthy Adults: 2 Years of Follow-up Compared With Natural Infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35986594" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Safety and immunogenicity of Zika virus vaccine: A systematic review of clinical trials.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
